Molecular and Cellular Mechanism of Action of Chrysotile Asbestos in MRC5 Cell Line

Author:

Kussainova Assiya12ORCID,Bulgakova Olga2ORCID,Aripova Akmaral2ORCID,Ibragimova Milana23ORCID,Pulliero Alessandra1ORCID,Begimbetova Dinara3,Bersimbaev Rakhmetkazhi2,Izzotti Alberto45ORCID

Affiliation:

1. Department of Health Sciences, University of Genova, Via Pastore 1, 16132 Genoa, Italy

2. Department of General Biology and Genomics, Institute of Cell Biology and Biotechnology, L.N. Gumilyov Eurasian National University, Astana 010008, Kazakhstan

3. National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan

4. Department of Experimental Medicine, University of Genoa, 16132 Genoa, Italy

5. IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy

Abstract

Asbestos is a known carcinogen; however, the influence of chrysotile asbestos on the development of tumor-related diseases remains a subject of intense debate within the scientific community. To analyze the effect of asbestos, we conducted a study using the MRC5 cell line. We were able to demonstrate that chrysotile asbestos stimulated the production of reactive oxygen species (ROS), leading to cell death and DNA damage in the MRC5 cell line, using various techniques such as ROS measurement, comet assay, MTT assay, and qPCR. In addition, we found that chrysotile asbestos treatment significantly increased extracellular mitochondrial DNA levels in the culture medium and induced significant changes in the expression profile of several miRNAs, which was the first of its kind. Thus, our research highlights the importance of studying the effects of chrysotile asbestos on human health and reveals multiple adverse effects of chrysotile asbestos.

Funder

Ministry of Science and Higher Education of the Republic of Kazakhstan

Italian Association for Cancer Research

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference54 articles.

1. Jenkins, R., Walker, J., and Roy, U.B. (Future Oncol., 2023). 2022 cancer statistics: Focus on lung cancer, Future Oncol., epub ahead of print.

2. Kaidarova, D.R. (2022). Indicators of the Oncology Service of the Republic of Kazakhstan, 2021, KazIOR.

3. (2022, April 15). National Cancer Institute: Surveillance, Epidemiology, and End Results Program, Available online: https://seer.cancer.gov/.

4. (2020, December 10). International Agency for Research on Cancer (IARC). Available online: https://www.iarc.who.int/.

5. Asbestos-related lung cancer and malignant mesothelioma of the pleura: Selected current issues;Markowitz;Semin. Respir. Crit. Care Med.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3